Stroke Therapeutics Market To Grow At A CAGR of 5% in The Next Five Years


(prsubmissionsite) October 16, 2019 – The 
global stroke therapeutics market size is poised to reach USD 1.37 billion by 2023, according to a new report by Technavio, progressing at a CAGR of close to 5% during the forecast period.

“Apart from the high-risk factors for stroke, the development of novel therapies, increasing awareness about stroke, and strategic alliances are some of the other major aspects expected to boost market growth during the forecast period,” says a senior analyst at Technavio. 

The market is driven by high-risk factors for stroke. In addition, growth of geriatric population is anticipated to further boost the stroke therapeutics market during the forecast period.

Stroke is the second-leading cause of death globally among adults. The increase in risk factors such as high blood pressure, high cholesterol levels, heart diseases, diabetes, and smoking are considered to be the major drivers for the growth of the market.

Download the free sample report @ http://bit.ly/31kUgV6

Furthermore, the growth of the geriatric population is contributing to the occurrence of strokes globally. Increase in age leads to frailty and higher risk of comorbidities, which has a major impact on the tolerance to intensive treatment modalities. Therefore, the rise in the geriatric population is expected to increase the incidence a stroke which in turn will drive market expansion during the forecast period.

The report includes detailed profiles of the leading companies & prominent vendors of the market:

·         Amgen Inc.

·         AstraZeneca Plc

·         Bayer AG

·         Boehringer Ingelheim International GmbH

·         Bristol-Myers Squibb Co.

·         F. Hoffmann-La Roche Ltd.

·         Johnson & Johnson Services Inc.

·         Merck & Co. Inc.

·         Pfizer Inc.

·         Sanofi

Market Segmentation by Category and Product Types:

The stroke therapeutics market can be broadly categorized into the following:

·         Ischemic stroke

·         Hemorrhagic stroke

 

Get the Complete Report @ http://bit.ly/31odARH

Key Regions for the Stroke Therapeutics Market:

Featuring a breakdown of region-wise market shares until 2019.

·         North America

·         Europe

·         Asia

·         ROW

Some of the key topics covered in the report include:

Market Landscape

·         Market ecosystem

·         Market characteristics

·         Market segmentation analysis

 

Market Sizing

·         Market definition

·         Market size and forecast

 

Vendor Landscape

·         Vendors covered

·         Vendor classification

·         Market positioning of vendors

·         Competitive scenario

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com